Skip to main content
OpenTrials

Clinical trial condition

Hyperpituitarism

Explore clinical trials studying Hyperpituitarism. Study availability and eligibility vary by location and protocol.

211 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Hyperpituitarism trial results

Completed

Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegalic Patients

NCT01278342

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • Novartis Investigative Site Brest, France
  • Novartis Investigative Site Bron, France
  • Novartis Investigative Site Le Kremlin-Bicêtre, France
  • Novartis Investigative Site Nice, France
View all 20 locations
View Trial Details
Completed

Octreotide Efficacy and Safety in First-line Acromegalic Patients

NCT00171886

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • Novartis Investigative site A Coruña, Spain
  • Novartis Investigative site Alicante, Spain
  • Novartis Investigative site Barcelona, Spain
  • Novartis Investigative site Burgos, Spain
View Trial Details
Completed

Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients

NCT00088582

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of Michigan Medical Center Ann Arbor, Michigan, United States
  • New York University/VA Medical Center New York, United States
View Trial Details
Completed

Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease

NCT00434148

Conditions
Brain Diseases, Central Nervous System Diseases, Cushing's Disease, +6 more
Locations
  • Stanford University Medical Center Stanford Cancer Center (3) Stanford, California, United States
  • University Chicago Hospital Dept. of Univ of Chicago Chicago, Illinois, United States
  • Dana Farber Cancer Institute The Melanoma Program Boston, Massachusetts, United States
  • Columbia University Medical Center- New York Presbyterian Columbia University DeptofMed New York, United States
View all 68 locations
View Trial Details

Related conditions